Akcea Therapeutics Inc. (AKCA) gained 5.73% or 1.3 to $23.97. It is nearly 124688 shares traded, which is 29.13% compare to the average total volume 427987. The market cap of AKCA is $1.60 billion. The year to date change is 30.44%. The 52 week price range is from $8.1 to $33.99. Price of AKCA have changed -8.33% during last week. It have changed 16.62% over last month, 45.60% over last 3 months, -11.82% over last 6 months and 139.14% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKCA is 23.25. It is -3.00% below current price. The 200-day Moving Averages for AKCA is 20.08. It is -16.23% below current price. The 52-week High is 33.99. It is 41.80% from the current price. The 52-week Low is 8.1. It is -66.21% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of AKCA is 10.21 on 2018-03-15. Short % to float is 7.48%. There are some statistics of AKCA. It is has market cap $1.60 billion. The share outstanding is 66.72 million. The average volume is 427987. The revenue is 37.17M. It has 529.32M cash and 9.50M in debt. The percent of top 15 Institution holding is 31.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKCA is -484.42%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKCA is -78.12%.